Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC) (Molecular Imaging and Biology, (2014), 16, 3, (431-440), 10.1007/s11307-013-0699-7)

Lanell M. Peterson, Brenda F. Kurland, Erin K. Schubert, Jeanne M. Link, V. K. Gadi, Jennifer M. Specht, Janet F. Eary, Peggy Porter, Lalitha K. Shankar, David A. Mankoff, Hannah M. Linden

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

Two data points from Table 1. (continued) were published in error. The corrected data in Table 1. (continued) are shown, in italic, below.

Original languageEnglish (US)
Number of pages1
JournalMolecular Imaging and Biology
Volume21
Issue number1
DOIs
StatePublished - Feb 15 2019

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC) (Molecular Imaging and Biology, (2014), 16, 3, (431-440), 10.1007/s11307-013-0699-7)'. Together they form a unique fingerprint.

  • Cite this